Aligos Therapeutics, Inc. (ALGS)

NASDAQ: ALGS · Real-Time Price · USD

12.00

-1.30 (-9.74%)

At close: Dec 15, 2025, 4:00 PM EST

12.06

+0.06 (0.50%)

After-hours: Dec 15, 2025, 5:53 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Novel Therapeutics	3.95M	Log In	Log In	Log In
Novel Therapeutics Growth	-74.60%	Log In	Log In	Log In